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Abstract
Background: Whereas coronary artery ectasia (CAE) is a rare abnormality of the coronary
arteries, co-existent coronary artery disease (CAD) is commonly seen in CAE patients. Since
a causative relationship has been shown to exist between oxidative stress and CAD, we sought
to determine whether any relationship exists between oxidative stress and CAE.
Methods: Fourty four patients with CAE (without CAD) and 86 controls (without any
coronary disease) were recruited from among 1,520 patients undergoing coronary angiogra-
phy. CAE subgroups were determined in accordance with the Markis classification system.
Mean values for serum total oxidant status (TOS), total antioxidant status (TAS) and the
oxidative stress index (OSI) were statistically compared between these two study groups and
among CAE subgroups, with p = 0.05 set as the threshold for statistical significance.
Results: TOS and OSI were significantly increased (p = 0.018 and 0.0002) and TAS
decreased (p = 0.031) in the CAE versus control group. TOS and TAS were independently
related to CAE (p = 0.037 and 0.039), with an r2 of 0.127. Interestingly, however, among CAE
subgroups, no differences were observed.
Conclusions: Oxidative stress might be implicated in the pathogenesis of CAE. Clinically-
-defined CAE subgroups did not differ in terms of oxidative stress status. However, the clinical
implications of these findings are unclear and warrant further investigation. (Cardiol J 2010;
17, 5: 488–494)
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Introduction
Coronary artery ectasia (CAE), a rare variant
of coronary artery abnormality, has been defined as
a coronary artery segment that has dilated to a dia-
meter that exceeds the diameter of adjacent seg-
ments, or the diameter of the largest coronary ar-
tery, by at least 50% [1]. The incidence of CAE has
been reported as between 0.5% and 4.9% in diffe-
rent series [1–4].
CAE may be congenital or acquired. Acquired
causes include coronary artery disease (CAD), Ka-
wasaki disease, various infectious and inflammato-
ry diseases, Ehlers-Danlos syndrome, Marfan syn-
drome, familial hypercholesterolemia, scleroderma,
connective tissue disorders like SLE, and vasculi-
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tides like polyarteritis nodosa, Takayasu’s disease
and Behcet’s syndrome [5–14].
Oxidative stability is defined as a balance be-
tween the formation and elimination of free radicals.
Any increase in the rate of free radical formation,
or decrease in their elimination, can disrupt this
balance, resulting in oxidative stress [15, 16]. Oxi-
dative stress usually is associated with increased
free radical formation, causing increased concentra-
tions of reactive oxygen species (ROS). ROS mo-
dify phospholipids and proteins, leading to lipid per-
oxidation and the oxidation of thiol groups [17, 18].
These substances may lead to inflammatory re-
sponses, including complement activation, the re-
lease of cytokines, leukocyte activation, and the
expression of adhesion molecules [19]. ROS also
cause the depletion of plasma antioxidants, forma-
tion of several damaging metabolites, and potential
DNA damage [20, 21]. Exogenous antioxidant mol-
ecules like vitamin E and C; endogenic antioxidants
that include albumin, uric acid, and bilirubin; and
scavenger enzymes like superoxide dismutase, glu-
tathione peroxidase and catalase may prevent
and/or inhibit the harmful effects of ROS [22].
CAE and CAD have several characteristics in
common. CAE can cause ischemic heart disease,
and even myocardial infarctions in patients without
CAD, by means of reduced and sluggish flow,
thrombus formation, and vasospasm [23, 24]. CAE
and coronary atherosclerosis exhibit similar histo-
pathological patterns [25]. Moreover, CAD is com-
monly seen in CAE patients and these two diseas-
es are closely related, with 70% of CAEs co-exis-
tent with atherosclerosis and only 20–30% isolated
[5, 6, 11].
In addition, a causative association between
oxidative stress and CAD has been detected in se-
veral clinical studies [26–28]. Based on the common
features of CAD and CAE, their frequent co-exist-
ence, and the proven association between CAD and
oxidative stress, our study sought to measure oxi-
dative status in CAE patients to determine if a rela-
tionship exists. Because CAE and CAD are so com-
monly observed together, to assess the independent
relationship between CAE and oxidative stress, we
selected CAE patients without CAD. To our know-
ledge, this is the first study to assess the association
between oxidative stress and isolated CAE.
Methods
Subjects
The study was conducted at Harran Universi-
ty School of Medicine. Prior to initiating subject
recruitment, the study was approved by the local
ethics committee of the university, in accordance
with the ethical principles for human investigations,
as outlined in the second Declaration of Helsinki.
All subjects provided written informed consent
prior to participating.
Between 2008 and 2009, 44 CAE patients (coro-
nary artery ectasia group; 19 females, 26 males,
mean age 62 years) without coronary artery disease
(defined as 50% or more narrowing in at least one
coronary artery since significant CAD has been re-
ported to be associated with the presence of in-
creased oxidative stress) [29] were recruited from
a total of 1,520 patients who underwent angiogra-
phy. As a control group, 86 patients [normal coro-
nary artery group (NCA); 52 females, 34 males,
mean age 61 years] with normal coronary arteries
were recruited from the same patient population.
Patients were deemed ineligible for analysis if any
of the following conditions were present: 1) any co-
existing cardiac disease, such as heart failure or
arrhythmia, a previous history of myocardial infarc-
tion, or coronary artery disease; 2) any evidence of
liver, kidney or respiratory disease; 3) acute coro-
nary syndrome; 4) malignancy; 5) any infectious,
inflammatory or infiltrative disorder; 6) recent use
(within 48 h) of any drug with anti-oxidant properties,
such as nebivolol, carvedilol, vitamins E and C, and
acetylcysteine; and 7) regular alcohol use or alco-
hol use within 48 hours.
Study design
This was a prospective case-control study.
Before angiography, all patients were examined in
detail. A medical history and detailed physical ex-
amination were recorded for each patient. The pa-
tients underwent routine laboratory workup for
renal and liver function, and other routine baseline
parameters. Erythrocyte sedimentation rate (ESR),
C reactive protein (CRP), and urinalysis (UA) were
obtained, and various numbers of electrocardio-
grams (ECG) were performed. A chest X-ray was
obtained and echocardiography performed on each
patient.
On angiography, a diagnosis of CAE was ren-
dered if any 1.5-fold or greater dilatation was evi-
dent, relative to adjacent normal coronary segments
[1]. After angiography, eligible CAE patients and
controls were recruited. Potentially-eligible pa-
tients and controls were selected in such a way as
to achieve a certain degree of homogeneity, in
terms of age, diabetes mellitus, hypertension,
smoking status and other demographic variables
(Table 1). CAE patients were divided into sub-
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groups, in accordance with the Markis classification
system, as follows: Type 1 CAE, diffuse ectasia in
two or three vessels; Type 2 CAE, diffuse ectasia
in one vessel and localized ectasias in at least one
other vessel; Type 3 CAE, diffuse ectasia in a single
vessel; Type 4 CAE, localized and segmentary ecta-
sia lesions.
Assays
All blood samples were obtained following an
overnight fast, drawn from a large antecubital vein
without interruption of venous flow, using a 19-gauge
butterfly needle connected to a plastic syringe.
Twenty milliliters [mL] of blood were drawn, with
the first few ml discarded. Ten mL were used for
baseline routine laboratories and ESR. The residu-
al content of the syringe was transferred immedia-
tely to polypropylene tubes. These tubes then were
centrifuged at 3,000 rpm for 10 minutes at 10–
–18oC. Supernatant plasma samples were stored in
plastic tubes at –80oC until assayed. For serum mark-
ers of oxidant stress, total oxidant status (TOS) was
measured and the oxidative stress index (OSI) cal-
culated. Total antioxidant capacity (TAS) was mea-
sured as an indicator of antioxidant status.
Measurement of TAS
Serum TAS was determined using a novel au-
tomated measurement method, developed by Erel
[30]. By this method, hydroxyl radical, the most
potent biological radical, is produced. In the assay,
ferrous ion solution, present in Reagent 1, is mixed
with hydrogen peroxide, which is present in Re-
agent 2. Sequentially-produced radicals like the
brown-colored dianisidinyl radical cation, produced
by the hydroxyl radical, also are potent radicals.
Using this method, the anti-oxidative effect of the
sample against potent free-radical reactions, which
are initiated by the produced hydroxyl radical, can
be measured. The assay has excellent precision
values, of greater than 97%. The results are ex-
pressed as mmol Trolox equiv./L.
Table 1. Demographic characteristics and laboratory parameters of subjects.
Parameters NCA CAE P
Age (years) 6.106 ± 9.48 62.42 ± 11.23 0.465
Sex (female/male) 52/34 20/25 0.80
Diabetes mellitus (+/–) 25/61 14/31 0.808
Hypertension (+/–) 29/57 14/31 0.763
Dyslipidemia (+/–) 20/66 16/29 0.134
Cigarette smoking (+/–) 22/64 12/33 0.893
Heart rate [beat/min] 78.09 ± 12.94 82.93 ± 14.66 0.066
ASP [mm Hg] 132.12 ± 27.31 129.89 ± 25.36 0.667
ADP [mm Hg] 83.71 ± 14.53 81.22 ± 13.82 0.373
Waist circumference [cm] 103.85 ± 13.65 106.22 ± 13.68 0.534
BSA [m2] 1.81 ± 0.23 1.89 ± 0.24 0.167
BMI [kg/m2] 28.14 ± 6.12 28.83 ± 4.70 0.606
QT [ms] 392.76 ± 34.72 377.30 ± 45.74 0.065
QTc [ms] 431.08 ± 35.26 429.10 ± 36.92 0.794
Urea [mg/dL] 38.49 ± 26.11 48.64 ± 28.15 0.180
Creatinine [mg/dL] 0.89 ± 0.13 0.93 ± 0.37 0.610
Fasting glucose [mg/dL] 138.83 ± 75.26 143.81 ± 53.69 0.796
AST [U/L] 18.91 ± 4.78 44.75 ± 50.80 0.108
ALT [U/L] 29.83 ± 5.95 31.75 ± 8.97 0.544
Total cholesterol [mg/dL] 197.65 ± 48.89 200.86 ± 33.80 0.800
LDL-C [mg/dL] 118.27 ± 47.73 131.23 ± 38.42 0.315
HDL-C [mg/dL] 42.08 ± 6.02 38.13 ± 8.05 0.067
Triglyceride [mg/dL] 165.25 ± 106.88 208.71 ± 108.97 0.185
From independent samples t-test and c2 analysis. Values are mean ± standard deviation; NCA — normal coronary artery group; CAE — coronary
artery ectasia group; ASP — arterial systolic pressure; ADP — arterial diastolic pressure; BSA — body surface area; BMI — body-mass index;
QTc — corrected QT interval; AST — aspartate aminotransferase; ALT — alanine aminotransferase; LDL-C — low-density lipoprotein-cholesterol;
HDL-C — high-density lipoprotein-cholesterol
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Measurement of TOS
The TOS of serum was determined using
a novel automated measurement method, also de-
veloped by Erel [31]. Oxidants present in the sam-
ple oxidize the ferrous ion-o-dianisidine complex to
ferric ion. The oxidation reaction is enhanced by
glycerol molecules, which are abundant in the re-
action medium. The ferric ion generates a coloured
complex with Xylenol Orange in an acidic medium.
Colour intensity, which can be measured spectro-
photometrically, is related to the quantity of oxidant
molecules present in the sample. The assay is cali-
brated with hydrogen peroxide and the results ex-
pressed in terms of micro-molar hydrogen peroxi-
de equivalents per liter (mmol H2O2 equiv./L).
Oxidative stress index
The OSI is defined as the ratio of the TOS to
TAS level, expressed as a percentage. For the cal-
culation, TAS units were changed to mmol/L, and
the OSI value calculated according to the following
formula (4): OSI (arbitrary unit) = TOS (mmol H2O2
Equiv./L)/TAS (mmol Trolox equiv./L).
Other variables
Serum sodium (Na), potassium (K), urea, cre-
atinine, fasting blood sugar, aspartate amino trans-
ferase (AST), alanine amino transferase (ALT), tri-
glyceride (TG), total cholesterol (TC), HDL-choles-
terol (HDL-C), and LDL-cholesterol (LDL-C) levels
were determined using commercially-available as-
say kits (Abbott®) with an auto-analyser (Aeroset®,
Germany). CRP was measured by means of
nephelometric analysis (NA Latex CRP reagent:
Behring Institute, Marburg, Germany). ESR was
measured using a modified Westergren method
(Dispette 2; Ulster Medical Products, a division of
Lukens Medical Corporation, Albuquerque, New
Mexico, USA).
Statistical analysis
All data analysis was conducted using SPSS
version 11.5 (SPSS Inc., Chicago, Illinois, USA),
with group parameters expressed as means ± stan-
dard deviations. Between-group comparisons were
conducted by independent samples Student’s
t-tests for continuous variables, and by Pearson’s
c2 analysis for categorical variables. Subgroup ana-
lyses were performed by one-way analysis of vari-
ance (ANOVA). Because the assumption of homo-
geneity of variance was met and the data was
approximately normally distributed, post-hoc com-
parisons were performed using Tukey’s procedure.
Differences at p £ 0.05 were interpreted as statis-
tically significant. For logistic regression analysis,
the ENTER variable selection method, and Hosmer
and Lemeshow goodness-of-fit test were used.
A Nagelkerke test was utilized to calculate R square.
All inferential tests were two-tailed.
Results
Demographic characteristics and routine labo-
ratory data for the two comparison groups are
shown in Table 1. There were no statistically sig-
nificant differences between the two groups with
regard to age (within the insignificance border),
gender, body mass index, body surface area, QT and
cQT interval, the rates of diabetes mellitus, hyper-
tension, dyslipidemia, cigarette smoking, electro-
lytes, or other routine biochemical parameters. The
serum TAS level was significantly lower in the CAE
group than in the NCA group (p = 0.018; Fig. 1),
whereas the TOS level and OSI value were signifi-
cantly higher in the CAE group (p = 0.031 and
0.0002, respectively; Fig. 1; Table 2). On logistic
regression analysis, an independent relationship
was identified between the presence of CAE and
both the TOS and TAS levels (b = 0.875, c2 = 4.35,
p = 0.049; b = –0.830, c2 = 4.35, p = 0.04 respec-
tively), with R2 = 0.127. Comparing the four differ-
ent subgroups of CAE, there were no statistically-
significant differences in TOS, TAS or OSI (Fig. 2).
Discussion
The present study generated two main results.
The first is that, in patients with CAE, two oxida-
tive parameters (TAS and OSI) were significantly
elevated, while antioxidant parameters were signi-
ficantly decreased, relative to normal controls with-
out CAE or CAD. The second finding is that the
serum oxidative parameters did not vary between
CAE subgroups, differentiated in terms of the num-
ber and distribution of lesions. To the best of our
knowledge, this is the first study to assess oxida-
tive stress in patients with CAE.
CAE resembles atherosclerosis in several re-
spects. One piece of supporting evidence for this
statement is that the two diseases (CAE and CAD)
have similar risk factors [1, 2]. Secondly, patients
with CAE commonly have co-morbid CAD [5, 6, 11].
Third, the two conditions exhibit similar histopatho-
logical features [25]. Based upon these common
features, we intended to research whether these
two disorders share certain metabolic features.
Accordingly, and since markers of oxidative stress
already have been shown to be elevated in CAD
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patients [26–28], we sought to determine whether
such markers also are high in patients with isola-
ted CAE.
Recently-published studies have revealed ox-
idative stress to be independently related to CAD
in regression models. However, it is not clear
Table 2. Oxidative/anti-oxidative markers in coronary artery ectasia group (CAE) and normal coronary
artery group (NCA).
Parameters NCA CAE P
Total antioxidant status [mmol Trolox equiv./L] 0.85 ± 0.11 0.80 ± 0.13 0.018
Total oxidant status [mmol H2O2 equiv./L] 10.82 ± 1.50 11.41 ± 1.43 0.031
Oxidative stress index [arbitrary unit] 1.30 ± 0.23 1.46 ± 0.27 0.00002
From independent samples t-test. Values are mean ± standard deviation.
Figure 1. A. Total antioxidant status (TAS) values by subject group; B. Total oxidant status (TOS) values by subject
group; C. Oxidative stress index (OSI) values by subject group; NCA — normal coronary artery group; CAE —
coronary artery ectasia group.
Figure 2. A. Total antioxidant status (TAS) values by coronary artery ectasia group (CAE) subgroup; B. Total oxidant
status (TOS) values by CAE subgroup; C. Oxidative stress index (OSI) values by CAE subgroup; Type 1, 2, 3 and 4 —
subgroups. Mean values are shown in the figure.
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whether oxidative stress is a direct cause of CAD
or the result of several metabolic pathways. Ne-
vertheless, irrespective of how it happens, it has
been concluded that oxidative stress has some caus-
ative role in atherosclerosis formation, though the
net effect might be small [26–28, 32].
In this study, we identified a similar effect in
CAE patients. We found two markers of oxidative
stress to be significantly higher in those with CAE
than in controls without either CAE or CAD. Fur-
thermore, upon regression analysis, TAS was found
to be independently related to CAE, predicting
roughly 13% of the variance in CAE presence, pro-
viding evidence implicating oxidative stress in CAE
pathogenesis. However, as mentioned above, this
relationship might be the result of various unknown
relationships and interactions. Consequently,
though the results of this study might not explain
why CAD and CAE share certain features, they
provide evidence that certain common pathophysi-
ological pathways might be at play [3–5].
On the other hand, the second main finding of
the current study was the lack of any of the differ-
ences that we might have anticipated between CAE
subgroups classified according to lesion number and
distribution. And, although the subgroup samples
admittedly were relatively small, the average sub-
group oxidant/antioxidant levels were nearly the
same, and the data was distributed normally, sug-
gesting that larger samples may not alter these
negative results. This means that oxidative status
might have a role in the pathogenesis of CAE. This
is an important finding because, as mentioned
above, the relationship of oxidative stress with CAE
could be causative, or it could be that oxidative
stress is a result of CAE. It was not possible for us
to clarify this effect in the current study. However,
we can conclude that oxidative stress is either
a cause, or a result, of various metabolic pathways.
This study is worth reporting for several rea-
sons. To begin with, the method by which we eva-
luated antioxidant status is relatively new and had
not been validated previously. Measuring total ox-
idative status is more valid and reliable, since there
are a great number of oxidants and antioxidants in
the body. When you measure only a few parame-
ters, you may find their levels unchanged or de-
creased, even when actual oxidant status is in-
creased, or vice versa. Secondly, isolated CAE is
relatively rare; and, in terms of evaluating oxida-
tive status, this study was the first. As mentioned
above, CAD is common in patients with CAE. How-
ever, we only recruited CAE patients without CAD.
Therefore, we clearly observed oxidative stress in-
creased in CAE separate from CAD, though diffe-
rent severities of CAE appeared to exert no influence.
Conclusions
The clinical implications of these results are
elusive, and whether increased oxidative stress
might respond to antioxidant treatment also is elu-
sive. However, if drug management is needed for
CAE (as in the cases of co-existing CAD, coronary
symptoms, or hypertension) using drugs with anti-
oxidant properties (e.g. nebivolol for hypertension
instead of other beta-blockers) might be preferred.
However, further studies are needed to draw clear-
cut conclusions.
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